Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 44: 2480-2489, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (37)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitfield, J. B.
Right arrow Articles by Martin, N. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitfield, J. B.
Right arrow Articles by Martin, N. G.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 1998;44:2480-2489.)
© 1998 American Association for Clinical Chemistry, Inc.


Enzymes and Protein Markers

Smoking, obesity, and hypertension alter the dose–response curve and test sensitivity of carbohydrate-deficient transferrin as a marker of alcohol intake

John B. Whitfield1,a, Linda M. Fletcher2, Theresa L. Murphy2, Lawrie W. Powell2, June Halliday2, Andrew C. Heath3 and Nicholas G. Martin2

1 Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia.

2 The Queensland Institute of Medical Research, Brisbane 4029, Australia.

3 Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63130.
a Author for correspondence. Fax 61 2 9515 7931; e-mail johnwhit{at}bioc.rpa.cs.nsw.gov.au.

Serum carbohydrate-deficient transferrin (CDT) is a specific and comparatively sensitive marker of excessive alcohol use; however, reports of its sensitivity vary according to the population or patient groups studied and their average alcohol intake. We have characterized the dose–response curve between alcohol intake and CDT concentrations in a study of 1400 men and women from a community-based twin registry. Our results show that mean CDT increases with increasing reported alcohol consumption even within the range of alcohol use considered to be nonhazardous. We found significant effects of sex, age, smoking, previous alcohol dependence, body mass index, and diastolic hypertension on the alcohol-CDT dose–response curve. These variables either affect test sensitivity or require adjustment of reference intervals. The results also provide insight into the physiological and biochemical factors that affect CDT concentration.




The following articles in journals at HighWire Press have cited this article:


Home page
CirculationHome page
D. T. O'Connor, G. Zhu, F. Rao, L. Taupenot, M. M. Fung, M. Das, S. K. Mahata, M. Mahata, L. Wang, K. Zhang, et al.
Heritability and Genome-Wide Linkage in US and Australian Twins Identify Novel Genomic Regions Controlling Chromogranin A: Implications for Secretion and Blood Pressure
Circulation, July 15, 2008; 118(3): 247 - 257.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
J. P. Bergstrom and A. Helander
Clinical Characteristics of Carbohydrate-Deficient Transferrin (%Disialotransferrin) Measured by HPLC: Sensitivity, Specificity, Gender Effects, and Relationship with other Alcohol Biomarkers
Alcohol Alcohol., July 1, 2008; 43(4): 436 - 441.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. B. Whitfield, V. Dy, P. A.F. Madden, A. C. Heath, N. G. Martin, and G. W. Montgomery
Measuring Carbohydrate-Deficient Transferrin by Direct Immunoassay: Factors Affecting Diagnostic Sensitivity for Excessive Alcohol Intake
Clin. Chem., July 1, 2008; 54(7): 1158 - 1165.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J.-J. Hottenga, J. B. Whitfield, D. Posthuma, G. Willemsen, E. J.C. de Geus, N. G. Martin, and D. I. Boomsma
Genome-Wide Scan for Blood Pressure in Australian and Dutch Subjects Suggests Linkage at 5P, 14Q, and 17P
Hypertension, April 1, 2007; 49(4): 832 - 838.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Valle, D. T. O'Connor, P. Taylor, G. Zhu, G. W. Montgomery, P. E. Slagboom, N. G. Martin, and J. B. Whitfield
Butyrylcholinesterase: Association with the Metabolic Syndrome and Identification of 2 Gene Loci Affecting Activity
Clin. Chem., June 1, 2006; 52(6): 1014 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. M.R. Appenzeller and R. Wennig
Altered Distribution of Transferrin Isoforms According to Serum Storage Conditions
Clin. Chem., November 1, 2005; 51(11): 2159 - 2162.
[Full Text] [PDF]


Home page
Alcohol AlcoholHome page
N. K. HANSELL, D. PANG, A. C. HEATH, N. G. MARTIN, and J. B. WHITFIELD
ERYTHROCYTE ALDEHYDE DEHYDROGENASE ACTIVITY: LACK OF ASSOCIATION WITH ALCOHOL USE AND DEPENDENCE OR ALCOHOL REACTIONS IN AUSTRALIAN TWINS
Alcohol Alcohol., September 1, 2005; 40(5): 343 - 348.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Van Campenhout, C. Van Campenhout, A. R. Lagrou, and B. Manuel-y-Keenoy
Effects of in Vitro Glycation on Fe3+ Binding and Fe3+ Isoforms of Transferrin
Clin. Chem., September 1, 2004; 50(9): 1640 - 1649.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
M. Fleming and M. Mundt
Carbohydrate-Deficient Transferrin: Validity of a New Alcohol Biomarker in a Sample of Patients with Diabetes and Hypertension
J Am Board Fam Med, July 1, 2004; 17(4): 247 - 255.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. B. Whitfield
Transferrin Isoform Analysis for the Diagnosis and Management of Hazardous or Dependent Drinking
Clin. Chem., December 1, 2002; 48(12): 2095 - 2096.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
J. B. Whitfield, G. Zhu, J. E. Nestler, A. C. Heath, and N. G. Martin
Genetic Covariation between Serum {gamma}-Glutamyltransferase Activity and Cardiovascular Risk Factors
Clin. Chem., September 1, 2002; 48(9): 1426 - 1431.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
A. Reif, H. Keller, M. Schneider, S. Kamolz, A. Schmidtke, and A. J. Fallgatter
CARBOHYDRATE-DEFICIENT TRANSFERRIN IS ELEVATED IN CATABOLIC FEMALE PATIENTS
Alcohol Alcohol., November 1, 2001; 36(6): 603 - 607.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Arndt
Carbohydrate-deficient Transferrin as a Marker of Chronic Alcohol Abuse: A Critical Review of Preanalysis, Analysis, and Interpretation
Clin. Chem., January 1, 2001; 47(1): 13 - 27.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G. Brathen, K. S Bjerve, E. Brodtkorb, and G. Bovim
Validity of carbohydrate deficient transferrin and other markers as diagnostic aids in the detection of alcohol related seizures
J. Neurol. Neurosurg. Psychiatry, March 1, 2000; 68(3): 342 - 348.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.